Groupe la Francaise increased its stake in shares of OR Royalties Inc. (NYSE:OR – Free Report) by 122.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 200,000 shares of the basic materials company’s stock after buying an additional 110,000 shares during the period. Groupe la Francaise owned about 0.11% of OR Royalties worth $7,591,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Linden Thomas Advisory Services LLC grew its position in shares of OR Royalties by 4.1% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 6,254 shares of the basic materials company’s stock valued at $221,000 after acquiring an additional 249 shares during the period. FCA Corp TX increased its stake in OR Royalties by 0.8% in the first quarter. FCA Corp TX now owns 39,647 shares of the basic materials company’s stock valued at $1,507,000 after acquiring an additional 330 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of OR Royalties by 6.2% during the 4th quarter. Wells Fargo & Company MN now owns 5,901 shares of the basic materials company’s stock valued at $209,000 after purchasing an additional 346 shares during the last quarter. Allworth Financial LP grew its position in OR Royalties by 20.0% during the fourth quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock valued at $82,000 after acquiring an additional 384 shares during the last quarter. Finally, Cetera Investment Advisers raised its position in OR Royalties by 3.5% in the 2nd quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company’s stock worth $337,000 after purchasing an additional 440 shares during the period. 68.52% of the stock is currently owned by hedge funds and other institutional investors.
OR Royalties Price Performance
NYSE OR opened at $29.74 on Friday. The stock has a market capitalization of $5.57 billion, a PE ratio of 22.19 and a beta of 0.74. The business has a 50 day simple moving average of $32.15 and a two-hundred day simple moving average of $37.57. OR Royalties Inc. has a 1-year low of $27.54 and a 1-year high of $48.06.
OR Royalties Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th were paid a dividend of $0.065 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This is a positive change from OR Royalties’s previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a yield of 0.9%. OR Royalties’s payout ratio is currently 18.66%.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on OR. Weiss Ratings lowered OR Royalties from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, July 24th. Jefferies Financial Group dropped their price target on shares of OR Royalties from $40.00 to $34.00 and set a “hold” rating on the stock in a research note on Monday, July 6th. Zacks Research downgraded OR Royalties from a “hold” rating to a “strong sell” rating in a report on Monday, July 13th. Scotiabank dropped their target price on shares of OR Royalties from $51.00 to $42.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 14th. Finally, Royal Bank Of Canada dropped their target price on OR Royalties from $50.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $40.50.
Check Out Our Latest Stock Report on OR Royalties
About OR Royalties
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Read More
- Five stocks we like better than OR Royalties
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding OR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OR Royalties Inc. (NYSE:OR – Free Report).
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
